News BrainsWay Ltd. Nasdaq

Equities

BWAY

US10501L1061

Market Closed - Nasdaq Other stock markets 01:30:00 08/06/2024 am IST			5-day change	1st Jan Change
6.44 ^USD	-0.92%		+2.38%	-0.62%

03/06	Brainsway's Deep Transcranial Magnetic Stimulation Gets Expanded FDA Labeling; Shares Rise	MT
03/06	BrainsWay Ltd. Receives Expanded FDA Labeling to Treat Late Life Depression	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Brainsway's Deep Transcranial Magnetic Stimulation Gets Expanded FDA Labeling; Shares Rise	03/06	MT
BrainsWay : Deep TMS™ Becomes the First and Only TMS Device Indicated for Depression Treatment in Patients Between the Ages of 68 and 86 - Form 6-K	03/06	PU
BrainsWay Receives Expanded FDA Labeling to Treat Late Life Depression	03/06	AQ
BrainsWay Ltd. Receives Expanded FDA Labeling to Treat Late Life Depression	03/06	CI
BrainsWay : Corporate Presentation May 2024	20/05	PU
BrainsWay : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K	10/05	PU
BrainsWay : Immediate Report of Meeting	10/05	PU
Oppenheimer Adjusts Brainsway Price Target to $11 From $10, Maintains Outperform Rating	09/05	MT
HC Wainwright Adjusts Price Target on Brainsway to $15 From $13, Keeps Buy Rating	09/05	MT
Transcript : BrainsWay Ltd., Q1 2024 Earnings Call, May 08, 2024	08/05
BrainsWay Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05	CI
BrainsWay Reports First Quarter 2024 Financial Results and Operational Highlights	08/05	AQ
BrainsWay Ltd. Reiterates Revenue Guidance for the Year 2024	08/05	CI
BrainsWay to Report First Quarter 2024 Financial Results on May 8, 2024	24/04	AQ
BrainsWay Expands Deep TMS™ Access in Israel Following Significant Increase in Reimbursement Rates	17/04	AQ
Brainsway Expands Deep Tms Access in Israel Following Significant Increase in Reimbursement Rates	17/04	CI
BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS™ to Treat Parkinson's Disease	04/04	AQ
BrainsWay Ltd. Announces Publish Review Results Highlighting Potential of Deep Transcranial Magnetic Stimulation (Deep TMS?) as a Novel Therapeutic Approach for Parkinson's Disease	04/04	CI
BrainsWay : Report of Periodic or Interim Report	29/03	PU
BrainsWay Announces Positive Results in Late-Life Depression Post-Marketing Analysis	28/03	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News BrainsWay Ltd. Nasdaq

Equities

BWAY

US10501L1061

Summary

Filters